HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S M Mansour Haeryfar Selected Research

COVID-19 Vaccines

12/2021A vesicular stomatitis virus-based prime-boost vaccination strategy induces potent and protective neutralizing antibodies against SARS-CoV-2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S M Mansour Haeryfar Research Topics

Disease

16Neoplasms (Cancer)
05/2022 - 05/2002
11Infections
01/2020 - 01/2005
7Septic Shock (Toxic Shock Syndrome)
05/2018 - 06/2009
3Virus Diseases (Viral Diseases)
01/2020 - 02/2011
3Cytokine Release Syndrome
06/2017 - 01/2017
2Sepsis (Septicemia)
01/2021 - 01/2015
2Human Influenza (Influenza)
01/2020 - 01/2008
2Colonic Neoplasms (Colon Cancer)
01/2019 - 01/2014
2Scarlet Fever
09/2017 - 05/2014
2Arthritis (Polyarthritis)
07/2012 - 10/2010
2Rheumatoid Arthritis
07/2012 - 10/2010
2Influenza in Birds (Avian Flu)
03/2010 - 11/2009
2Mastocytoma
03/2003 - 05/2002
1Ascites
05/2022
1Ovarian Neoplasms (Ovarian Cancer)
05/2022
1Ovarian Epithelial Carcinoma
05/2022
1COVID-19
12/2021
1Vesicular Stomatitis
12/2021
1Hypersensitivity (Allergy)
01/2021
1Superinfection
01/2020
1Thymoma (Thymic Carcinoma)
10/2019
1Skin Neoplasms (Skin Cancer)
01/2019
1Inflammation (Inflammations)
01/2019
1Polyps
01/2019
1Leishmaniasis
01/2018
1Disease Progression
01/2018
1Gram-Positive Bacterial Infections
01/2017
1Acquired Immunodeficiency Syndrome (AIDS)
11/2016
1Communicable Diseases (Infectious Diseases)
10/2016
1Abscess
09/2014
1Bacteremia
09/2014
1Cowpox
01/2005

Drug/Important Bio-Agent (IBA)

10SuperantigensIBA
01/2020 - 06/2009
7LigandsIBA
05/2022 - 03/2008
5Proteins (Proteins, Gene)FDA Link
01/2019 - 07/2012
4CytokinesIBA
05/2022 - 01/2008
4VaccinesIBA
12/2021 - 01/2005
4GlycolipidsIBA
10/2016 - 03/2008
4AntigensIBA
10/2016 - 11/2009
3EpitopesIBA
01/2020 - 01/2008
2ChemokinesIBA
01/2021 - 09/2014
2Antiviral Agents (Antivirals)IBA
01/2020 - 01/2019
2AntibodiesIBA
01/2020 - 09/2017
2Peptides (Polypeptides)IBA
01/2019 - 11/2017
2Interleukin-17 (Interleukin 17)IBA
12/2018 - 01/2017
2Histocompatibility Antigens Class IIIBA
05/2018 - 05/2014
2Virulence Factors (Pathogenicity Factors)IBA
09/2017 - 05/2014
2staphylococcal enterotoxin BIBA
09/2017 - 06/2009
2nef Gene Products (nef Gene Product)IBA
01/2017 - 11/2016
2HLA-DR4 Antigen (HLA DR4 Antigen)IBA
09/2014 - 07/2012
2ExotoxinsIBA
05/2014 - 06/2009
2CitrullineIBA
07/2012 - 10/2010
2Galactosylceramides (Galactocerebrosides)IBA
02/2011 - 03/2008
2Hemagglutinins (Hemagglutinin)IBA
03/2010 - 11/2009
1RNA (Ribonucleic Acid)IBA
05/2022
1COVID-19 VaccinesIBA
12/2021
1Neutralizing AntibodiesIBA
12/2021
1SolutionsIBA
12/2021
1Histocompatibility Antigens Class IIBA
01/2021
1HaptensIBA
01/2021
1Granzymes (Granzyme)IBA
10/2019
1EstersIBA
01/2019
1Peptide Hydrolases (Proteases)FDA Link
01/2019
16-carboxyfluorescein (carboxyfluorescein)IBA
01/2019
1CateninsIBA
01/2019
15-(6)-carboxyfluorescein diacetate succinimidyl ester (CFSE)IBA
01/2019
1Monoclonal AntibodiesIBA
11/2018
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
05/2018
1TOR Serine-Threonine KinasesIBA
01/2018
1MTOR InhibitorsIBA
01/2018
1Pharmaceutical PreparationsIBA
01/2018
1Bevacizumab (Avastin)FDA Link
12/2017
1Cytokine Receptors (Cytokine Receptor)IBA
12/2017
1Streptococcus pyogenes SpeA proteinIBA
09/2017
1Immunoglobulins (Immunoglobulin)IBA
06/2017
1Mucin-3IBA
06/2017
1LipidsIBA
10/2016
1Interleukin-12 (IL 12)IBA
09/2014
1Interferon-gamma (Interferon, gamma)IBA
09/2014
1Staphylococcal enterotoxin AIBA
09/2014
1ToxoidsIBA
05/2014
1erythrogenic toxinIBA
01/2014
1Viral AntigensIBA
01/2014
1Single-Chain AntibodiesIBA
01/2014
1Ethylene Oxide (Oxirane)IBA
05/2013
1polycaprolactoneIBA
05/2013
1C-galactosylceramideIBA
07/2012
1HLA Antigens (Human Leukocyte Antigens)IBA
07/2012
1serum P-component (CIt)IBA
10/2010
1Immunoglobulin G (IgG)IBA
10/2010
1Fibrinogen (Factor I)FDA Link
10/2010
1T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
11/2009
1Peptidoglycan (Murein)IBA
06/2009
1Toll-Like Receptor 2IBA
06/2009

Therapy/Procedure

8Immunotherapy
05/2022 - 03/2008
3Therapeutics
01/2021 - 02/2011
1Ligation
01/2021
1Punctures
01/2021
1Drug Therapy (Chemotherapy)
12/2017
1Critical Care (Surgical Intensive Care)
01/2015